Tscan Therapeutics Inc (TCRX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.6050 +0.0150 (+0.94%) 04/30/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.6292 +0.0242 (+1.51%) 19:27 ET
for Wed, Apr 30th, 2025
Results
download Want to compare other data? Select Fields| Symbol | TCRX | BDTX | ANIX | ||
| Company | Tscan Therapeutics Inc | Black Diamond Therapeutics Inc | Anixa Biosciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.5500 | 1.5500 | 2.76 | ||
| High | 1.6450 | 1.7150 | 2.88 | ||
| Low | 1.4800 | 1.5250 | 2.70 | ||
| Last | 1.6050 | 1.7000 | 2.79 | ||
| Change | +0.0150 | +0.1000 | +0.04 | ||
| % Change | +0.94% | +6.25% | +1.45% | ||
| Volume | 290,300 | 742,700 | 53,000 | ||
| 20-Day Average Volume | 508,625 | 1,004,770 | 47,765 | ||
| Previous Close | 1.5900 | 1.6000 | 2.75 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.3858 | 1.4820 | 2.68 | ||
| 20-Day Raw Stochastic | 82.39% | 97.09% | 83.61% | ||
| 20-Day Relative Strength | 50.22% | 52.37% | 49.92% | ||
| Weighted Alpha | -75.70 | -74.53 | -7.19 | ||
| Today's Opinion | 72% Sell | 64% Sell | 72% Sell | ||
| Previous Opinion | 72% Sell | 88% Sell | 72% Sell | ||
| Last Month's Opinion | 100% Sell | 100% Sell | 48% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.53% since 04/23/25 | +7.59% since 04/23/25 | +2.20% since 04/23/25 | ||
| Low | 1.4800 on 04/30/25 | 1.5250 on 04/30/25 | 2.65 on 04/28/25 | ||
| High | 1.7300 on 04/24/25 | 1.7150 on 04/30/25 | 2.88 on 04/30/25 | ||
| 1-Month | |||||
| %Chg | +18.89% since 03/28/25 | +5.59% since 03/28/25 | -6.06% since 03/28/25 | ||
| Low | 1.0200 on 04/09/25 | 1.2000 on 04/09/25 | 2.33 on 04/08/25 | ||
| High | 1.7300 on 04/24/25 | 1.7150 on 04/30/25 | 2.97 on 04/01/25 | ||
| 3-Month | |||||
| %Chg | -37.79% since 01/30/25 | -32.54% since 01/30/25 | -5.10% since 01/30/25 | ||
| Low | 1.0200 on 04/09/25 | 1.2000 on 04/09/25 | 2.33 on 04/08/25 | ||
| High | 2.6700 on 02/03/25 | 2.8200 on 01/31/25 | 3.32 on 03/25/25 | ||
| 6-Month | |||||
| %Chg | -66.07% since 10/30/24 | -40.77% since 10/30/24 | -22.28% since 10/30/24 | ||
| Low | 1.0200 on 04/09/25 | 1.2000 on 04/09/25 | 2.07 on 01/14/25 | ||
| High | 6.2250 on 11/07/24 | 3.4400 on 11/12/24 | 4.20 on 11/08/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 89,980 | 90,683 | 88,542 | ||
| Shares Outstanding, K | 56,591 | 56,677 | 32,197 | ||
| Annual Sales | 2,820,000 | 0 | 0 | ||
| Annual Net Income | -127,500,000 | -69,680,000 | -12,550,000 | ||
| Last Quarter Sales | 670,000 | 0 | 0 | ||
| Last Quarter Net Income | -35,810,000 | -15,990,000 | -3,180,000 | ||
| 60-Month Beta | 1.09 | 2.81 | 0.52 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.29 on 03/05/25 | -0.28 on 03/06/25 | -0.10 on 03/11/25 | ||
| Latest Earnings Date | 05/12/25 | 05/08/25 | 06/03/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||